Biotech Showcase

Thank you for your interest in presenting at Biotech Showcase 2018.

If you completed an investor summary for the previous year you can retrieve it using our search tool here.

Please note, all Biotech Showcase presenting companies are required to pay both the registration fee ($1795) and presentation fee (public companies, $3950; private companies, $1950). Also, please provide a phone number where we can reach you in the event the Presenter Selection Committee has questions about your request to present form.

To be considered for a presentation slot at Biotech Showcase 2018, please complete the following Investor Summary Profile. This information will be used to evaluate your request to present at the Biotech Showcase 2018. If selected to present at Biotech Showcase 2018 all or portions of this information will be used as follows:

  • - Posted on the Biotech Showcase 2018 website and used in promotional materials.
  • - Distributed to investors and other biopharmaceutical executives prior to the conference.
  • - Published in the Biotech Showcase 2018 Handbook of Presenting Companies.

Please be as accurate as possible. Demy-Colton and EBD Group reserves the right to edit the information you provide to meet our formatting needs as well as to ensure accuracy.

Please complete the following fields
Indicates a required field

Company Name
(Please provide full and complete legal company name)
Presenter's Contact Name
Presenter's Job Title
Presenter's Contact Email
Presenter's Contact Phone
Assistant's Name
Assistant's Email
Assistant's Phone
Company Structure Public Private
IPO Year (if public)
Primary Stock Exchange (if public)
Ticker Symbol (if public)
If private, do you intend to go public before the conference? Yes No
Investor Summary This information is required for communications and marketing. If it cannot be completed now, please return to this form and complete it at a later date.
Location
Country:
Street Address:
City:
State/Province:
Zip/Postal:
Year Established
Website
Number of Employees
Company Classification Please select primary and secondary, if applicable

Therapeutic Focus/Product Please select primary , secondary and tertiary and any additional, if applicable

Technology/Target/Product
Please describe your development program

How many assets do you have in each of the following development phases?

Phase No. Assets Therapeutic Focus (Select up to 5)
Pre-Clinical
Phase I
Phase II
Phase III
Funding Plans Biotech Showcase 2018 is an investor conference. Please let us know your fundraising plans:
Current Major Investors
Corporate Partners
Funds Raised to Date
Additional Comments